2010
DOI: 10.1007/s00018-010-0577-2
|View full text |Cite
|
Sign up to set email alerts
|

HLA-G: a look back, a look forward

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
1

Year Published

2014
2014
2019
2019

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(8 citation statements)
references
References 30 publications
0
7
1
Order By: Relevance
“…This is in contrast to a previous study by Kronsteiner et al [ 24 ] which reported that PTEC alone do not secrete sHLA-G. However, unlike our study, Kronsteiner et al did not stimulate PTEC with IFN-γ, which induces the expression of sHLA-G. Functionally, the role of sHLA-G has been demonstrated to be beneficial in various clinical conditions including pregnancy, transplantation and various inflammatory diseases [ 25 , 26 ]. In kidney models, the presence of HLA-G in renal allograft biopsies [ 27 ] and increased sHLA-G levels in plasma samples from kidney transplant patients [ 28 ] have both correlated with improved kidney graft acceptance.…”
Section: Discussioncontrasting
confidence: 99%
“…This is in contrast to a previous study by Kronsteiner et al [ 24 ] which reported that PTEC alone do not secrete sHLA-G. However, unlike our study, Kronsteiner et al did not stimulate PTEC with IFN-γ, which induces the expression of sHLA-G. Functionally, the role of sHLA-G has been demonstrated to be beneficial in various clinical conditions including pregnancy, transplantation and various inflammatory diseases [ 25 , 26 ]. In kidney models, the presence of HLA-G in renal allograft biopsies [ 27 ] and increased sHLA-G levels in plasma samples from kidney transplant patients [ 28 ] have both correlated with improved kidney graft acceptance.…”
Section: Discussioncontrasting
confidence: 99%
“…The mechanisms underlying this lack of protein variability detected for HLA-G are not well understood, mainly because HLA-G is located within the most variable genes of the human genome. This phenomenon is also observed for other non-classical HLA genes such as HLA-E and HLA-F, which present tolerogenic and immune modulatory properties (Rizzo et al, 2008;Donadi et al, 2011;Nilsson et al, 2016;Mendes-Junior et al, 2013;Castelli et al, 2011;Zambra et al, 2016;Hviid et al, 2006;Lima et al, 2016;Castelli et al, 2015;Castelli et al, 2014b;Veiga-Castelli et al, 2016;Dias et al, 2015;Felicio et al, 2014;Veiga-Castelli et al, 2012;Castelli et al, 2007;Hviid et al, 1997;Hviid et al, 1999;Hviid et al, 2001;Hviid et al, 2003;Carosella, 2011;Carosella and LeMaoult, 2011;Arnaiz-Villena et al, 2007a;Arnaiz-Villena et al, 2007b;Alegre et al, 2007;Moscoso et al, 2006;Carvalho dos Santos et al, 2013;Liu et al, 2012). Considering the 500 samples studied here, only six different protein molecules would be encoded by the HLA-G sequences observed: G*01:01 (69.3%), G*01:03 (7.8%), G*01:04 (15.10%), G*01:05N (2.2%), G*01:06 (5.4%) and G*01:11 (0.2%).…”
Section: Discussionmentioning
confidence: 70%
“…The HLA expression at feto‐maternal interface can be associated with a successful pregnancy (Ellis, Palmer, & McMichael, ; Kovats et al, ). HLA‐G (OMIM: 142871) is normally expressed in several locations such as fetal trophoblasts, pancreatic islets, and endothelial precursors (Carosella & LeMaoult, ). HLA‐G protects fetal trophoblast cells toward the maternal uterine NK cells during pregnancy (Abediankenari, Farzad, Rahmani, & Hashemi‐Soteh, ).…”
Section: Human Leukocyte Antigensmentioning
confidence: 99%